The contract manufacturer Excelvision, in partnership with Laboratoires Thea, inaugurate their new sterile manufacturing facility on 26 January 2017 : 4000m2, two production lines and the infrastructure for 5 lines in the future.
Excelvision installed on the Lombardière Industrial zone in Annonay (Ardèche), is an affiliate of the Fareva Group, the lead Pharmaceutical CMO in Europe.
Laboratoires Thea based in Clermont Ferrand (Puy de Dôme) is the third largest European Ophthalmic specialist.
The two new BFS (Blow Fill Seal) lines allow Excelvision to push their capacity for the production of preservative free eye drops in single dose units from 500 to 800 million vials per year.
This investment will allow Excelvision to accompany Laboratoires Thea for the manufacture under aseptic conditions of their “Latanaprost” eye-drop developed for the treatment of glaucoma.
A Pharmaceutical Laboratory and a CMO – both French, both family owned organisations, both internationally renowned – joined in partnership to ensure the development of their companies with the construction of a new manufacturing facility for an investment of 28M€ leading to the future recruitment of 90 employees.
By meeting the high level requirements of the Pharmaceutical Industry while significantly increasing production capacity, by recruiting locally with specifically developed training programs, Thea and Excelvision actively participate in the development of industry in France, its presence throughout the world and the defense of employment.